Torsade de pointes, QT interval prolongation and renal disease

International Journal of Cardiology

Volumn 149, Issue 2, 2011, Pages 241-242

  Patanè, Salvatore ^a  

^a Cardiologia Nuovo Presidio Ospedaliero Cutroni Zodda Barcellona PdG(Me)   (Italy)

Author keywords

Chronic renal failure; Torsade de pointes; Ventricular tachycardia

Indexed keywords

DIURETIC AGENT; FLUCONAZOLE; SOTALOL;

ACUTE HEART INFARCTION; AGED; ANAMNESIS; BLOOD PRESSURE MEASUREMENT; CASE REPORT; ELECTROCARDIOGRAPHY; EMERGENCY WARD; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY DISEASE; LETTER; OXYGEN SATURATION; PRIORITY JOURNAL; QT PROLONGATION; STROKE; TORSADE DES POINTES;

EID: 79957501394     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.10.126     Document Type: Article

References (16)

1. R.M. Gowda, I.A. Khan, S.L. Wilbur, B.C. Vasavada, and T.J. Sacchi Torsade de pointes: the clinical considerations Int J Cardiol 96 1 Jul 2004 1 6 Review (Pubitemid 38760232)
2. S. Patanè, F. Marte, and G. Di Bella QT interval prolongation and torsade de pointes Int J Cardiol 131 2 Jan 9 2009 e51 e53 Electronic publication ahead of print 2007 Aug 8
3. P. Nisse, S. Soubrier, F. Saulnier, and M. Mathieu-Nolf Torsade de pointes: a severe and unknown adverse effect in indoramin self-poisoning Int J Cardiol 133 2 Apr 3 2009 e73 e75 Electronic publication ahead of print 2008 Jan 9
4. C. De Gregorio, G. Morabito, M. Cerrito, G. Dattilo, and G. Oreto Citalopram-induced long QT syndrome and torsade de pointes: role for concomitant therapy and disease Int J Cardiol 2009 Jun 21 Electronic publication ahead of print
5. S. Kanjanauthai, T. Kanluen, and P. Chareonthaitawee Citalopram induced torsade de pointes, a rare life threatening side effect Int J Cardiol 131 1 Dec 17 2008 e33 e34 Electronic publication ahead of print 2007 Oct 4
6. C.P. Pham, P.W. de Feiter, P.H. van der Kuy, and W.N. van Mook Long QTc interval and torsade de pointes caused by fluconazole Ann Pharmacother 40 7-8 Jul-Aug 2006 1456 1461 Electronic publication ahead of print 2006 Jul 18
7. K.P. Letsas, A. Sideris, S.P. Kounas, M. Efremidis, P. Korantzopoulos, and F. Kardaras Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine Int J Cardiol 109 2 May 10 2006 273 274 Electronic publication ahead of print 2005 Jun 1 (Pubitemid 44399739)
8. K. Yalta, O. Turgut, A. Yilmaz, M.B. Yilmaz, O. Kendirlioglu, and F. Karadas Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake Int J Cardiol 16 3 Apr 4 2007 e95 e97 Electronic publication ahead of print 2006 Nov 27
9. G.B. Kim, H.Y. Cho, and B.S. Kwon QT interval prolongation and ventricular fibrillation in childhood end-stage renal disease Int J Cardiol 127 (3 Jul 21 2008 e126 e128 Electronic publication ahead of print 2007 Aug 21
10. G.A. Stewart, R.T. Gansevoort, and P.B. Mark Electrocardiographic abnormalities and uremic cardiomyopathy Kidney Int 67 1 Jan 2005 217 226 (Pubitemid 40019243)
11. S. Patanè, F. Marte, G. Di Bella, A. Currò, and S. Coglitore QT interval prolongation, torsade de pointes and renal disease Int J Cardiol 130 2 Nov 12 2008 e71 e73 Electronic publication ahead of print 2008 Feb 5
12. P. Ball Quinolone-induced QT interval prolongation: a not-so-unexpected class effect J Antimicrob Chemother 45 2000 557 559 (Pubitemid 30255632)
13. R.C. Owens, and P.G. Ambrose Torsades de pointes associated with fluoroquinolones Pharmacotherapy 22 2002 663 668
14. J.L. Démolis, D. Kubitza, L. Tennezé, and C. Funck-Brentano Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects Clin Pharmacol Ther 68 2000 658 666 (Pubitemid 32059992)
15. T. Altin, O. Ozcan, and S. Turhan Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event Can J Cardiol 23 11 2007 Sep 907 908 (Pubitemid 350011275)
16. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2